Home   l   Log in   l     
HOME
NEWS

Singlera Genomics Raises $20 Million in Series A Financing Led by Lilly Asia Ventures 2016-8-26
Manufacturing Facility Ground Breaking and Contract-signing Ceremony for Third Round of Financing 2015-11-3
VERITAS GENETICS BREAKS $1,000 WHOLE GENOME BARRIER 2015-10-16
Database Locking of Icotinib Clinical Research Data Came to a Successful Conclusion 2012-5-23
Sinqi Pharmaceutical¡¯s new factory construction started on March 2012, which includes manufactory center, storage center, R&D center and ophthalmic pharmacologyexperiment center. 2012-5-23
BrightGene¡¯s new anti HBV drug was reported to fill the domestic balnk in China, and was approved to conduct clinical trials. 2012-5-23
Dr Lu from Shenzhen Chipscreen Biosciences was invited to speech at ¡°The 23rd National Economy Information Summit on Pharmaceutical Industry¡± (2011-11-14) 2012-5-23
HD Bioscience Co. LTD Received AAALAC Accreditation on Its Animal Facility 2012-5-23
HD Biosciences Launches Medicinal Chemistry for SAR Focused R&D Services 2012-5-23
HD Biosciences Ranks in ¡°2011 Deloitte Technology Fast 50 China¡± 2012-5-23
June 7, 2011, Conmana£¨Icotinib Hydrochloride Tablets£© was approvedfor the treatment of patients with advanced stage NSCLC by the State Food and Drug Administration (SFDA) of China, and was officially launched on August 12. 2012-5-23

1/1Page Total11

 Room 2909, 3 Corporate Avenue, No.168 Hubin Road  
 +86 21 2316 9588  
copyright © 2012-2015 Lilly Asia Ventures all rights reserved.